文献速递肝病消化道肿瘤与早癌

环状RNA circMTO1作为microRNA-9的海绵抑制肝细胞癌进展

Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression.
PubMed 文献 · Hepatology · 2017-08-26

研究分析人肝细胞癌组织中环状RNA表达谱,发现circMTO1在癌组织中显著下调,低表达患者生存期缩短。circMTO1作为致癌miR-9的海绵促进p21表达,抑制肝癌细胞增殖和侵袭;沉默circMTO1则促进肿瘤生长,该效应可被miR-9抑制剂阻断。

要点

  • circMTO1在肝细胞癌组织中显著下调,低表达患者生存期缩短。
  • circMTO1作为miR-9的海绵,促进p21表达,抑制肝癌细胞增殖和侵袭。
  • 沉默circMTO1的促瘤效应可被miR-9抑制剂阻断。

核心结论

  • circMTO1通过作为致癌miR-9的海绵促进p21表达,抑制肝细胞癌进展,提示circMTO1是肝癌治疗的潜在靶点。
  • 肝细胞癌组织中circMTO1降低可作为患者生存预后不良的预测指标。

研究设计与样本

  • 分析人环状RNA在肝细胞癌组织中的表达谱,鉴定circMTO1(hsa_circRNA_0007874/hsa_circRNA_104135)为显著下调的环状RNA。
  • 利用生物素标记的circMTO1探针在肝癌细胞中进行RNA体内沉淀,鉴定circMTO1相关miRNA。
  • 在肝癌细胞中沉默circMTO1,观察对p21、细胞增殖和侵袭的影响,并用miR-9抑制剂验证。
  • 在荷肝癌小鼠体内瘤内给予胆固醇偶联的circMTO1小干扰RNA,观察肿瘤生长。

主要发现

  • circMTO1在肝细胞癌组织中显著下调,低表达患者生存期缩短。
  • 生物素标记circMTO1探针RNA体内沉淀鉴定miR-9为circMTO1相关miRNA。
  • 沉默circMTO1可下调致癌miR-9的靶点p21,促进肝癌细胞增殖和侵袭。
  • circMTO1沉默的促瘤效应被miR-9抑制剂阻断。
  • 荷肝癌小鼠瘤内给予胆固醇偶联的circMTO1小干扰RNA促进肿瘤生长。

临床怎么用

  • 原文结论指出circMTO1是肝细胞癌治疗的潜在靶点,肝细胞癌组织中circMTO1降低可作为患者生存预后不良的预测指标。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Noncoding RNAs play important roles in cancer biology, providing potential targets for cancer intervention. As a new class of endogenous noncoding RNAs, circular RNAs (circRNAs) have been recently identified in cell development and function, and certain types of pathological responses, generally acting as a microRNA (miRNA) sponge to regulate gene expression. Identifying the deregulated circRNAs and their roles in cancer has attracted much attention. However, the expression profile and function of circRNAs in human hepatocellular carcinoma (HCC) remain to be investigated. Here, we analyzed the expression profile of human circRNAs in HCC tissues and identified circMTO1 (mitochondrial translation optimization 1 homologue; hsa_circRNA_0007874/hsa_circRNA_104135) as one circRNA significantly down-regulated in HCC tissues. HCC patients with low circMTO1 expression had shortened survival. By using a biotin-labeled circMTO1 probe to perform RNA in vivo precipitation in HCC cells, we identified miR-9 as the circMTO1-associated miRNA. Furthermore, silencing of circMTO1 in HCC could down-regulate p21, the target of oncogenic miR-9, resulting in the promotion of HCC cell proliferation and invasion. In addition, the tumor-promoting effect of circMTO1 silencing was blocked by miR9 inhibitor. Intratumoral administration of cholesterol-conjugated circMTO1 small interfering RNA promoted tumor growth in HCC-bearing mice in vivo. CONCLUSION: circMTO1 suppresses HCC progression by acting as the sponge of oncogenic miR-9 to promote p21 expression, suggesting that circMTO1 is a potential target in HCC treatment. The decrease of circMTO1 in HCC tissues may serve as a prognosis predictor for poor survival of patients. (Hepatology 2017;66:1151-1164).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Han D, Li J, Wang H, et al. Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression. Hepatology. 2017. PMID: 28520103. doi:10.1002/hep.29270

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。